VIR

Vir Biotechnology Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↑ 5/10
  • Value↓ 0/10
Vir Biotechnology sales and earnings growth
VIR Growth
Neutral
  • Revenue Y/Y↑ 213.96%
  • EPS Y/Y↑ 26.07%
  • FCF Y/Y↓ -7.32%
Vir Biotechnology gross and profit margin trends
VIR Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -676.00%
  • ROIC 5Y↓ -43.98%
Vir Biotechnology net debt vs free cash flow
VIR Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Vir Biotechnology stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks